Jeffrey A. Allen - Concepedia

Author

Jeffrey A. Allen

Also Known As

J A Allen, J Allen, J. A. ALLEN, J. A. Allen, J. Allen, J.A. Allen, Jadi Allen, Jeff Allen, Jeffrey A Allen, Jeffrey A. Allen

149

Publications

8.2K

Citations

H-Index

114

Concepts

All Affiliations

University of Minnesota Northwestern University University of Central Florida Cedars-Sinai Medical Center Syracuse University

About

Jeffrey A. Allen is an author at University of Minnesota specializing in medicine, business, and management.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	872
2	Business	8	8	3.9K
3	Management	7	7	3.8K
4	Health Sciences	2	2	55
5	Engineering	1	1	198

Jeffrey A. Allen

Publications

7.5K

Citations

H-Index

Page 1

	Year	Citations
The entrepreneur's business model: toward a unified perspective Michael H. Morris, Minet Schindehutte, Jeffrey A. Allen Journal of Business Research E-business ModelManagementBusinessBusiness Model CanvasBusiness Strategy	2004	2.5K
Correlates of success in family business transitions Michael H. Morris, Roy O. Williams, Jeffrey A. Allen, Journal of Business Venturing Family ManagementFamily Business StudiesManagementBusinessFamily Business Transitions	1997	665
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision Peter Van den Bergh, Pieter A. van Doorn, Robert D. M. Hadden, Journal of the Peripheral Nervous System	2021	461
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision Peter Van den Bergh, Pieter A. van Doorn, Robert D. M. Hadden, European Journal of Neurology	2021	416
A 12-Gene Set Predicts Survival Benefits from Adjuvant Chemotherapy in Non–Small Cell Lung Cancer Patients Hao Tang, Guanghua Xiao, Carmen Behrens, Clinical Cancer Research	2013	290
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial Ivo N. van Schaik, Vera Bril, Nan van Geloven, The Lancet Neurology Subcutaneous ImmunoglobulinAutoimmune DiseaseChronic InflammatoryMaintenance TreatmentImmunotherapy	2017	258
CIDP diagnostic pitfalls and perception of treatment benefit Jeffrey A. Allen, Richard A. Lewis Neurology	2015	238
Antecedents and Outcomes of Entrepreneurial and Market Orientations in a Non-profit Context: Theoretical and Empirical Insights Michael H. Morris, Susan Coombes, Minet Schindehutte, Journal of Leadership & Organizational Studies Market OrientationEntrepreneurial PhenomenonWork ClimateNon-profit ContextManagement	2007	216
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study James F. Howard, Saskia Bresch, Angela Genge, The Lancet Neurology MedicineSurgeryClinical TrialsGeneralised Myasthenia Gravis	2023	213
Individualism and the Modern Corporation: Implications for Innovation and Entrepreneurship Michael H. Morris, Ramon A. Avila, Jeffrey A. Allen Journal of Management International ManagementCultureEntrepreneurial InnovationFunctional Area ManagersEntrepreneurial Phenomenon	1993	207

Page 1